Exponent INC Form 4 insider transactions

Catherine Corrigan, Chief Executive Officer and a Director of Exponent Inc, reported multiple transactions in common stock on July 28, 2026.

Catherine Corrigan, Chief Executive Officer and a Director of Exponent Inc, sold 1,737 shares of common stock on July 15, 2026 for $62.78 per share.

Catherine Corrigan, CEO and Director of Exponent Inc., acquired 7,872 shares of common stock on June 25, 2026, at a price of $25.405 per share.

Exponent CEO Catherine Corrigan exercised stock options and sold shares to cover tax obligations and exercise costs.

Director Carol Lindstrom converted vested restricted stock units into common stock and received a new grant of restricted stock units.

Director George H. Brown converted vested restricted stock units into common stock and received a new grant of 2,859 units.

Director Karen Richardson converted 2,009 vested restricted stock units into common stock and received a new grant of 2,859 units.

Director Debra Zumwalt converted vested restricted stock units into common stock and received a new grant of restricted stock units.

Director Paul R. Johnston converted 2,009 vested Restricted Stock Units into Exponent Inc. common stock.

Exponent Inc. reports a Form 4 filing detailing a transaction by Group Vice President Bradley A. James.

Richard Reiss, Group Vice President at Exponent Inc., reported a transaction involving the sale of 1,672 shares of common stock.

Exponent Inc. President and CEO Catherine Corrigan exercised stock options and sold shares to cover associated costs.

Group Vice President Joseph Rakow sold 2,945 shares of Exponent Inc. common stock on May 13, 2026.

Exponent Inc. Group Vice President Joseph Sala sold 2,066 shares of common stock at an average price of $56.66.

Exponent CEO Catherine Corrigan exercised stock options and sold shares in a planned transaction under Rule 10b5-1.

Exponent Inc. VP John Pye reports the grant of stock options for 21,000 shares with an exercise price of $66.56.

Exponent's EVP & Chief Financial Officer, Richard L. Schlenker Jr., reported the acquisition of 10,688 Restricted Stock Units.

Exponent Inc. Group Vice President Joseph Sala was granted 9,798 Restricted Stock Units, vesting on March 13, 2030.

Exponent's Group Vice President, Maureen T.F. Reitman, acquired 9,500 restricted stock units in a transaction dated March 13, 2026.

Exponent's Group Vice President, Richard Reiss, reported the acquisition of 2,970 restricted stock units, vesting in 2030.

Exponent Inc. Group Vice President Joseph Rakow acquired 10,688 restricted stock units under a pre-arranged plan.

Exponent Inc.'s VP of Global Offices & Innovation, John Pye, acquired 5,938 Restricted Stock Units, vesting in March 2030.

Exponent's Chief Human Resources Officer, Brian Kundert, was granted 3,564 Restricted Stock Units, which are scheduled to vest in 2030.

Exponent Group Vice President Bradley A. James acquired 4,454 Restricted Stock Units, vesting in 2030, under a pre-arranged plan.

Exponent Group Vice President Richard Reiss converted vested Restricted Stock Units into common stock and subsequently disposed of shares, including those withheld for tax obligations.

Exponent's EVP & CFO, Richard L. Schlenker, Jr., converted 7,630 vested Restricted Stock Units into common stock and subsequently sold 3,694 shares to cover tax obligations.

Exponent's Group Vice President, Joseph Sala, converted vested Restricted Stock Units into common stock and subsequently sold a portion to cover tax obligations.

Exponent Group Vice President Maureen T.F. Reitman converted vested Restricted Stock Units into common stock and subsequently sold shares to cover tax obligations.

Exponent Group Vice President Joseph Rakow converted vested Restricted Stock Units into common stock and subsequently sold a portion to cover tax obligations.

Exponent Inc. VP John Pye converted vested Restricted Stock Units into common stock and sold shares to cover tax obligations.